Appian v. Pegasystems: How a $2 Billion Trade-Secret Verdict Came Undone

Appian Corp. v. Pegasystems, Inc., Record No. 240736 (Va. Jan. 8, 2026), is the trade-secret damages decision of the cycle. A Fairfax County jury had awarded Appian more than $2 billion — widely reported at approximately $2.036 billion, the largest damages award in Virginia history and among the largest trade-secret verdicts ever returned. The Court of Appeals of Virginia reversed that award in July 2024, and on January 8, 2026, the Supreme Court of Virginia affirmed the reversal. Liability survived; the headline number did not. The reason is a lesson every trade-secret litigant should absorb: proving misappropriation is not the same as proving damages, and a defendant’s revenue is not, without more, the plaintiff’s loss.

At a glance

• Case: Appian Corp. v. Pegasystems, Inc., Record No. 240736 (Supreme Court of Virginia)
• Key dates: Jury verdict May 2022; Court of Appeals reversal July 30, 2024; Supreme Court of Virginia affirmance January 8, 2026
• Holding: Liability for trade-secret misappropriation affirmed; the ~$2 billion damages award reversed and remanded for a new trial on damages because of an erroneous burden-shifting instruction
• Status: Remanded for a new trial limited to damages; the liability finding stands

The claim and the verdict

Appian and Pegasystems are competitors in business-process-management software. Appian alleged that Pega had obtained its confidential information — including through a contractor who accessed Appian’s platform — and used it to improve Pega’s competing product, in violation of the Virginia Uniform Trade Secrets Act (VUTSA). The jury agreed on liability and awarded damages measured by Pega’s sales: in essence, the revenue Pega earned during the period following the misappropriation.

It is the damages methodology, not the finding of misappropriation, that unraveled on appeal.

The instruction that sank the award

Under VUTSA, as under the Uniform Trade Secrets Act generally, a plaintiff may recover damages for the actual loss caused by misappropriation and for any unjust enrichment not captured by actual loss. The operative word is caused: the statute compensates harm attributable to the misappropriation, not all revenue a defendant happened to earn.

At trial, the jury was instructed in a way that shifted the burden on causation. Once Appian proved misappropriation and established Pega’s total post-misappropriation sales revenue, the instruction effectively required Pega to prove what portion of that revenue was not caused by the misappropriation — failing which the entire revenue figure could be treated as damages. The appellate courts held this was error. VUTSA places on the plaintiff the burden to prove that the misappropriation caused the damages it claims; the instruction improperly relieved Appian of that burden and allowed the jury to equate the defendant’s gross revenue with compensable harm. Because the error went to the heart of the damages award and could have produced the staggering figure the jury returned, a new trial on damages was required.

The Supreme Court of Virginia also clarified an aspect of trade-secret scope under VUTSA: information disclosed under circumstances implying an obligation of confidence can retain trade-secret status even without an express confidentiality contract. That portion supported the liability finding even as the damages award fell.

Why it matters beyond Virginia

VUTSA is Virginia’s enactment of the Uniform Trade Secrets Act, and the causation principle the court enforced is common to UTSA jurisdictions and echoes the federal Defend Trade Secrets Act. The decision’s reasoning therefore travels. Its central teaching — that a damages model equating a defendant’s total revenue with the plaintiff’s loss, without proof that the misappropriation caused that revenue, is legally infirm — is a caution to plaintiffs everywhere who are tempted to let a large, round revenue figure stand in for a rigorous causation analysis.

It is equally a reminder that the size of a verdict is no guarantee of its durability. A record-breaking award built on a flawed instruction is a fragile thing; the more a damages theory depends on burden-shifting or on revenue untethered from causation, the more exposed it is on appeal.

Open questions

The remand will test how Appian proves causation-linked damages on a proper instruction: whether it can tie specific Pega gains to the misappropriated information, and what figure a correctly instructed jury returns. More broadly, the case sharpens an unresolved tension in trade-secret law between unjust-enrichment recovery (which looks to the defendant’s gains) and the causation requirement (which demands a link to the misappropriation) — a tension that recurs whenever a plaintiff seeks to disgorge a defendant’s revenue.

Implications for litigants and businesses

• Plaintiffs: prove causation, not just revenue. Build a damages case that connects the misappropriation to identifiable gains or losses. Do not rely on instructions that shift the causation burden to the defendant.
• Defendants: attack the damages model and the instructions. Even where liability is strong, a revenue-equals-damages theory and any burden-shifting instruction are prime targets on appeal.
• For all companies: confidentiality can arise without a contract. Information shared under circumstances implying confidence may qualify as a trade secret — relevant to both protecting and respecting confidential information.

Frequently asked questions

Did Pegasystems win? Partially. It did not escape liability — the misappropriation finding was affirmed — but it succeeded in vacating the ~$2 billion damages award, which goes back for a new trial on damages.

What was wrong with the damages award? The jury was instructed in a way that let Appian treat Pega’s total post-misappropriation revenue as damages and shifted to Pega the burden of disproving causation. The courts held the plaintiff bears the burden to prove the misappropriation caused its claimed damages.

Does a trade secret require a signed confidentiality agreement? Not necessarily. The Supreme Court of Virginia confirmed that information shared under circumstances implying an obligation of confidence can remain a trade secret even absent an express contract.

Authorities and sources

• Appian Corp. v. Pegasystems, Inc., Record No. 240736 (Va. Jan. 8, 2026): opinion (Justia); decision-date summary (Virginia Appellate Law Blog).
• Analysis: Holland & Knight, “Virginia High Court Upholds Reversal of Trade Secret Damages Award”; Holland & Knight on the 2024 Court of Appeals reversal.